Hopewell Therapeutics

company

About

Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.

  • Boston,Massachusetts,United States
  • 11 - 50

Details

Last Funding Type
Seed
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing. It is intended to provide and services in the field of novel drug delivery systems.

The company was founded in 2018 and is based in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$15.11M
Hopewell Therapeutics has raised a total of $15.11M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 2, 2022 Series Unknown $7.10M Detail
Oct 8, 2021 Series Unknown $8M Detail
Sep 1, 2021 Seed 1 Massachusetts Avenue Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Hopewell Therapeutics is funded by 1 investors. Massachusetts Avenue Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Massachusetts Avenue Capital Yes Seed

Employee Profiles

Number of Employee Profiles
1
Hopewell Therapeutics has 1 current employee profiles, including Executive Qiaobing Xu
Executive